LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

Randomized phase II study of lapatinib plus capecitabine or lapatinib plus topotecan for patients with HER2-positive breast cancer brain metastases

Journal of Neuro-Oncology ◽

10.1007/s11060-011-0629-y ◽

2011 ◽

Vol 105 (3) ◽

pp. 613-620 ◽

Cited By ~ 111

Author(s):

Nancy U. Lin ◽

Wolfgang Eierman ◽

Richard Greil ◽

Mario Campone ◽

Bella Kaufman ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Randomized Phase Ii ◽

Faculty Opinions recommendation of Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.724195112.793501041 ◽

2014 ◽

Author(s):

Minesh Mehta ◽

Manmeet Ahluwalia

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer – A phase II study

Journal of the Egyptian National Cancer Institute ◽

10.1016/j.jnci.2014.08.001 ◽

2014 ◽

Vol 26 (4) ◽

pp. 187-194 ◽

Cited By ~ 9

Author(s):

Hanan Shawky ◽

Hesham Tawfik

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-1080 ◽

2009 ◽

Vol 15 (4) ◽

pp. 1452-1459 ◽

Cited By ~ 429

Author(s):

Nancy U. Lin ◽

Véronique Diéras ◽

Devchand Paul ◽

Dominique Lossignol ◽

Christos Christodoulou ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

Abstract P2-16-02: Bevacizumab, etoposide, and cisplatin (BEEP) is highly effective in brain metastases of HER2 positive breast cancer progressing from whole brain radiotherapy - Subgroup analysis of a multi-center phase II study

10.1158/0008-5472.sabcs13-p2-16-02 ◽

2013 ◽

Author(s):

Y-S Lu ◽

W-W Chen ◽

C-H Lin ◽

D-C Yeh ◽

L-M Tseng ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Subgroup Analysis ◽

Phase Ii Study ◽

Whole Brain Radiotherapy ◽

Her2 Positive ◽

Brain Radiotherapy ◽

Abstract OT1-08-05: Phase II trial of GDC-0084 in combination with trastuzumab for patients with HER2-positive breast cancer brain metastases (BCBM)

10.1158/1538-7445.sabcs19-ot1-08-05 ◽

2020 ◽

Author(s):

Jose P Leone ◽

Lorenzo Trippa ◽

Lindsey Milisits ◽

Chelsea Andrews ◽

Jennifer Ligibel ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Trial ◽

Her2 Positive ◽

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Yearbook of Oncology ◽

10.1016/s1040-1741(09)79359-5 ◽

2009 ◽

Vol 2009 ◽

pp. 13-14

Author(s):

J.T. Thigpen

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Yearbook of Neurology and Neurosurgery ◽

10.1016/s0513-5117(09)79092-1 ◽

2009 ◽

Vol 2009 ◽

pp. 126-127 ◽

Cited By ~ 1

Author(s):

J. Uhm

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Phase Ii ◽

Phase Ii Study ◽

Her2 Positive ◽

Multicenter Phase ◽

Abstract OT1-1-09: Opti-HER HEART: A prospective, multicenter, single-arm, phase II study to evaluate the safety of neoadjuvant liposomal doxorubicin plus paclitaxel, trastuzumab, and pertuzumab in patients with operable HER2-positive breast cancer.

10.1158/0008-5472.sabcs12-ot1-1-09 ◽

2012 ◽

Author(s):

J Gavilá ◽

A Llombart ◽

A Guerrero ◽

A Ruiz ◽

V Guillem

Keyword(s):

Breast Cancer ◽

Phase Ii ◽

Liposomal Doxorubicin ◽

Phase Ii Study ◽

Her2 Positive ◽

Abstract 4832: Preclinical evaluation of neratinib plus T-DM1 in orthotopic PDX models of HER2-positive breast cancer brain metastases

10.1158/1538-7445.am2019-4832 ◽

2019 ◽

Cited By ~ 1

Author(s):

Jing Ni ◽

Yanzhi Wang ◽

Irmina Diala ◽

Sheheryar Kabraji ◽

Rachel Freedman ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Her2 Positive ◽

Preclinical Evaluation ◽

Pdx Models ◽